nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—prostate cancer	0.39	1	CbGaD
Trandolapril—CES1—Capecitabine—prostate cancer	0.276	1	CbGbCtD
Trandolapril—ACE—urine—prostate cancer	0.00564	0.173	CbGeAlD
Trandolapril—CES1—Phase I biotransformations, non P450—PON1—prostate cancer	0.00505	0.0971	CbGpPWpGaD
Trandolapril—CES1—prostate gland—prostate cancer	0.00304	0.0936	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—CYP3A5—prostate cancer	0.00277	0.0532	CbGpPWpGaD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—prostate cancer	0.00226	0.0434	CbGpPWpGaD
Trandolapril—SLC15A1—epithelium—prostate cancer	0.00208	0.0638	CbGeAlD
Trandolapril—ACE—prostate gland—prostate cancer	0.00203	0.0623	CbGeAlD
Trandolapril—CES1—E2F transcription factor network—UXT—prostate cancer	0.00193	0.0371	CbGpPWpGaD
Trandolapril—SLC15A1—renal system—prostate cancer	0.00193	0.0592	CbGeAlD
Trandolapril—SLC15A2—prostate gland—prostate cancer	0.00177	0.0543	CbGeAlD
Trandolapril—ACE—seminal vesicle—prostate cancer	0.00171	0.0527	CbGeAlD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—prostate cancer	0.00164	0.0315	CbGpPWpGaD
Trandolapril—SLC15A2—seminal vesicle—prostate cancer	0.00149	0.0459	CbGeAlD
Trandolapril—ACE—epithelium—prostate cancer	0.00149	0.0458	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—UMPS—prostate cancer	0.00145	0.0279	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—CYP3A4—prostate cancer	0.00143	0.0275	CbGpPWpGaD
Trandolapril—ACE—renal system—prostate cancer	0.00138	0.0424	CbGeAlD
Trandolapril—ACE—urethra—prostate cancer	0.00136	0.0417	CbGeAlD
Trandolapril—CES1—testis—prostate cancer	0.00134	0.0412	CbGeAlD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.00125	0.0241	CbGpPWpGaD
Trandolapril—SLC15A2—renal system—prostate cancer	0.0012	0.037	CbGeAlD
Trandolapril—SLC15A2—urethra—prostate cancer	0.00118	0.0364	CbGeAlD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A1—prostate cancer	0.00116	0.0224	CbGpPWpGaD
Trandolapril—ACE—bone marrow—prostate cancer	0.00104	0.0321	CbGeAlD
Trandolapril—CES1—lymph node—prostate cancer	0.000972	0.0299	CbGeAlD
Trandolapril—ACE—testis—prostate cancer	0.000892	0.0274	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—CYP2A6—prostate cancer	0.000878	0.0169	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—APC—prostate cancer	0.000834	0.016	CbGpPWpGaD
Trandolapril—SLC15A2—testis—prostate cancer	0.000778	0.0239	CbGeAlD
Trandolapril—CES1—NRF2 pathway—CBR1—prostate cancer	0.000768	0.0148	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.000739	0.0142	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.000686	0.0132	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTM3—prostate cancer	0.000671	0.0129	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—NOS3—prostate cancer	0.000648	0.0125	CbGpPWpGaD
Trandolapril—ACE—lymph node—prostate cancer	0.000647	0.0199	CbGeAlD
Trandolapril—CES1—NRF2 pathway—SLC39A1—prostate cancer	0.000607	0.0117	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—MME—prostate cancer	0.000594	0.0114	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—XRCC1—prostate cancer	0.000582	0.0112	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TYMS—prostate cancer	0.000572	0.011	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—GRP—prostate cancer	0.000569	0.0109	CbGpPWpGaD
Trandolapril—SLC15A2—lymph node—prostate cancer	0.000564	0.0173	CbGeAlD
Trandolapril—CES1—E2F transcription factor network—SULT2A1—prostate cancer	0.000541	0.0104	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—ERCC2—prostate cancer	0.000532	0.0102	CbGpPWpGaD
Trandolapril—Fosinopril—ACE—prostate cancer	0.000504	0.111	CrCbGaD
Trandolapril—CES1—Fluoropyrimidine Activity—MTHFR—prostate cancer	0.0005	0.00961	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.000464	0.00892	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.000464	0.00892	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—ACHE—prostate cancer	0.000456	0.00876	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—CTSD—prostate cancer	0.000431	0.00829	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.000431	0.00828	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.000431	0.00828	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—TGFB1—prostate cancer	0.000429	0.00824	CbGpPWpGaD
Trandolapril—Perindopril—ACE—prostate cancer	0.000411	0.0909	CrCbGaD
Trandolapril—CES1—NRF2 pathway—GSTA3—prostate cancer	0.00041	0.00788	CbGpPWpGaD
Trandolapril—Spirapril—ACE—prostate cancer	0.000406	0.0898	CrCbGaD
Trandolapril—Moexipril—ACE—prostate cancer	0.00039	0.0861	CrCbGaD
Trandolapril—Benazepril—MTHFR—prostate cancer	0.000387	0.0855	CrCbGaD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.00038	0.00731	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA4—prostate cancer	0.000375	0.00721	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA2—prostate cancer	0.000365	0.00702	CbGpPWpGaD
Trandolapril—Cilazapril—ACE—prostate cancer	0.000362	0.0801	CrCbGaD
Trandolapril—Quinapril—ACE—prostate cancer	0.000362	0.0801	CrCbGaD
Trandolapril—Lisinopril—ACE—prostate cancer	0.000362	0.0801	CrCbGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—prostate cancer	0.000353	0.00678	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—BRCA1—prostate cancer	0.000353	0.00678	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA1—prostate cancer	0.000353	0.00678	CbGpPWpGaD
Trandolapril—Ramipril—ACE—prostate cancer	0.000351	0.0776	CrCbGaD
Trandolapril—CES1—NRF2 pathway—HSP90AB1—prostate cancer	0.000341	0.00656	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00033	0.00635	CbGpPWpGaD
Trandolapril—Benazepril—ACE—prostate cancer	0.000315	0.0697	CrCbGaD
Trandolapril—CES1—E2F transcription factor network—SIRT1—prostate cancer	0.000313	0.00601	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—NFE2L2—prostate cancer	0.000311	0.00597	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000306	0.00589	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—TYMS—prostate cancer	0.000303	0.00583	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGFBP6—prostate cancer	0.0003	0.00576	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—TUSC3—prostate cancer	0.0003	0.00576	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GPX3—prostate cancer	0.000296	0.0057	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFA—prostate cancer	0.000296	0.0057	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—CYP2A6—prostate cancer	0.000267	0.00513	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—SSR2—prostate cancer	0.000267	0.00513	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—GALNT3—prostate cancer	0.000267	0.00513	CbGpPWpGaD
Trandolapril—Enalapril—ACE—prostate cancer	0.000266	0.0588	CrCbGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000261	0.00502	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—PLAU—prostate cancer	0.00025	0.00481	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—SPON2—prostate cancer	0.000244	0.0047	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—HERPUD1—prostate cancer	0.000244	0.0047	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000242	0.00466	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—LEP—prostate cancer	0.000239	0.00459	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—ATM—prostate cancer	0.000237	0.00456	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC5A5—prostate cancer	0.000233	0.00447	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—KLK3—prostate cancer	0.000227	0.00437	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—NQO1—prostate cancer	0.000225	0.00432	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000224	0.0043	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—HSPA1A—prostate cancer	0.000223	0.00429	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPN2—prostate cancer	0.000214	0.0041	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—KLK2—prostate cancer	0.000214	0.0041	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MBTPS1—prostate cancer	0.000214	0.0041	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GGT1—prostate cancer	0.000209	0.00401	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—EGR1—prostate cancer	0.000209	0.00401	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000208	0.00399	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000207	0.00399	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000207	0.00399	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CREBBP—prostate cancer	0.000206	0.00397	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—INS—prostate cancer	0.000204	0.00392	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—TCP1—prostate cancer	0.000202	0.00389	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—IGF1—prostate cancer	0.000197	0.00379	CbGpPWpGaD
Trandolapril—Nateglinide—CYP3A5—prostate cancer	0.000197	0.0435	CrCbGaD
Trandolapril—CES1—NRF2 pathway—RXRA—prostate cancer	0.000195	0.00376	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—SERPINE1—prostate cancer	0.000194	0.00372	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—DNAJC3—prostate cancer	0.000193	0.00371	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000192	0.0037	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000192	0.0037	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TP53—prostate cancer	0.00019	0.00365	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFBR2—prostate cancer	0.000187	0.0036	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTP1—prostate cancer	0.000187	0.0036	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—GCNT1—prostate cancer	0.000185	0.00356	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PDIA3—prostate cancer	0.000178	0.00343	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTM1—prostate cancer	0.000172	0.00331	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—B4GALT4—prostate cancer	0.000172	0.00331	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—TPP1—prostate cancer	0.000172	0.00331	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF3H—prostate cancer	0.000172	0.00331	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000168	0.00323	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000168	0.00322	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—F9—prostate cancer	0.000167	0.0032	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDKN1B—prostate cancer	0.00016	0.00308	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MUC4—prostate cancer	0.000157	0.00303	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000156	0.003	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000156	0.00299	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDKN1A—prostate cancer	0.000148	0.00284	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—CTNNB1—prostate cancer	0.000146	0.00281	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—EP300—prostate cancer	0.000141	0.0027	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPL12—prostate cancer	0.000138	0.00264	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000137	0.00264	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000133	0.00255	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—HSP90B1—prostate cancer	0.00013	0.00251	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000127	0.00245	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF3A—prostate cancer	0.000126	0.00243	CbGpPWpGaD
Trandolapril—Enalapril—CYP3A4—prostate cancer	0.000125	0.0276	CrCbGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000123	0.00237	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—MYC—prostate cancer	0.000122	0.00235	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MME—prostate cancer	0.000112	0.00216	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000108	0.00208	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—GRP—prostate cancer	0.000107	0.00206	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000105	0.00203	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000105	0.00203	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPL10—prostate cancer	0.000104	0.002	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.0001	0.00193	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.0001	0.00192	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	9.78e-05	0.00188	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	9.78e-05	0.00188	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ATF3—prostate cancer	9.36e-05	0.0018	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	9.28e-05	0.00178	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGFBP3—prostate cancer	8.81e-05	0.00169	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ACHE—prostate cancer	8.6e-05	0.00165	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	8.55e-05	0.00164	CbGpPWpGaD
Trandolapril—Nateglinide—CYP3A4—prostate cancer	8.52e-05	0.0188	CrCbGaD
Trandolapril—ACE—Metabolism of proteins—RPS19—prostate cancer	8.27e-05	0.00159	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CTSD—prostate cancer	8.14e-05	0.00156	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—THBS1—prostate cancer	8.02e-05	0.00154	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	7.93e-05	0.00152	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	7.89e-05	0.00152	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CALR—prostate cancer	7.62e-05	0.00146	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	7.32e-05	0.00141	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFB1—prostate cancer	7.02e-05	0.00135	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.97e-05	0.00134	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	6.63e-05	0.00127	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PLAUR—prostate cancer	6.52e-05	0.00125	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.47e-05	0.00124	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	6.15e-05	0.00118	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.65e-05	0.00109	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.33e-05	0.00102	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.24e-05	0.00101	CbGpPWpGaD
Trandolapril—Hepatobiliary disease—Doxorubicin—prostate cancer	5.09e-05	0.000207	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.08e-05	0.000977	CbGpPWpGaD
Trandolapril—Epistaxis—Doxorubicin—prostate cancer	5.08e-05	0.000207	CcSEcCtD
Trandolapril—Anorexia—Capecitabine—prostate cancer	5.08e-05	0.000207	CcSEcCtD
Trandolapril—Nausea—Estradiol—prostate cancer	5.07e-05	0.000207	CcSEcCtD
Trandolapril—Vomiting—Mitoxantrone—prostate cancer	5.06e-05	0.000206	CcSEcCtD
Trandolapril—Visual impairment—Epirubicin—prostate cancer	5.03e-05	0.000205	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—prostate cancer	5.02e-05	0.000205	CcSEcCtD
Trandolapril—Rash—Mitoxantrone—prostate cancer	5.02e-05	0.000204	CcSEcCtD
Trandolapril—Dermatitis—Mitoxantrone—prostate cancer	5.01e-05	0.000204	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.01e-05	0.000204	CcSEcCtD
Trandolapril—Headache—Mitoxantrone—prostate cancer	4.98e-05	0.000203	CcSEcCtD
Trandolapril—Hypotension—Capecitabine—prostate cancer	4.98e-05	0.000203	CcSEcCtD
Trandolapril—Insomnia—Docetaxel—prostate cancer	4.97e-05	0.000203	CcSEcCtD
Trandolapril—Arthralgia—Prednisone—prostate cancer	4.95e-05	0.000202	CcSEcCtD
Trandolapril—Myalgia—Prednisone—prostate cancer	4.95e-05	0.000202	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.94e-05	0.00095	CbGpPWpGaD
Trandolapril—Paraesthesia—Docetaxel—prostate cancer	4.94e-05	0.000201	CcSEcCtD
Trandolapril—Erythema multiforme—Epirubicin—prostate cancer	4.94e-05	0.000201	CcSEcCtD
Trandolapril—Anxiety—Prednisone—prostate cancer	4.93e-05	0.000201	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—prostate cancer	4.92e-05	0.000201	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.91e-05	0.0002	CcSEcCtD
Trandolapril—Dyspnoea—Docetaxel—prostate cancer	4.9e-05	0.0002	CcSEcCtD
Trandolapril—Somnolence—Docetaxel—prostate cancer	4.89e-05	0.000199	CcSEcCtD
Trandolapril—Discomfort—Prednisone—prostate cancer	4.89e-05	0.000199	CcSEcCtD
Trandolapril—Eye disorder—Epirubicin—prostate cancer	4.88e-05	0.000199	CcSEcCtD
Trandolapril—Hypersensitivity—Etoposide—prostate cancer	4.88e-05	0.000199	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—prostate cancer	4.87e-05	0.000198	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.85e-05	0.000198	CcSEcCtD
Trandolapril—Flushing—Epirubicin—prostate cancer	4.85e-05	0.000198	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—prostate cancer	4.85e-05	0.000198	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—prostate cancer	4.84e-05	0.000197	CcSEcCtD
Trandolapril—Dyspepsia—Docetaxel—prostate cancer	4.84e-05	0.000197	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—prostate cancer	4.83e-05	0.000197	CcSEcCtD
Trandolapril—Insomnia—Capecitabine—prostate cancer	4.82e-05	0.000196	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—prostate cancer	4.8e-05	0.000195	CcSEcCtD
Trandolapril—Paraesthesia—Capecitabine—prostate cancer	4.78e-05	0.000195	CcSEcCtD
Trandolapril—Decreased appetite—Docetaxel—prostate cancer	4.78e-05	0.000195	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—prostate cancer	4.77e-05	0.000195	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—prostate cancer	4.76e-05	0.000194	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Docetaxel—prostate cancer	4.75e-05	0.000194	CcSEcCtD
Trandolapril—Asthenia—Etoposide—prostate cancer	4.75e-05	0.000194	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—prostate cancer	4.75e-05	0.000194	CcSEcCtD
Trandolapril—Dyspnoea—Capecitabine—prostate cancer	4.75e-05	0.000194	CcSEcCtD
Trandolapril—Oedema—Prednisone—prostate cancer	4.74e-05	0.000193	CcSEcCtD
Trandolapril—Fatigue—Docetaxel—prostate cancer	4.74e-05	0.000193	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—prostate cancer	4.74e-05	0.000193	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—prostate cancer	4.74e-05	0.000193	CcSEcCtD
Trandolapril—Nausea—Mitoxantrone—prostate cancer	4.73e-05	0.000193	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.72e-05	0.000907	CbGpPWpGaD
Trandolapril—Immune system disorder—Epirubicin—prostate cancer	4.72e-05	0.000192	CcSEcCtD
Trandolapril—Infection—Prednisone—prostate cancer	4.71e-05	0.000192	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—prostate cancer	4.71e-05	0.000192	CcSEcCtD
Trandolapril—Constipation—Docetaxel—prostate cancer	4.7e-05	0.000192	CcSEcCtD
Trandolapril—Dyspepsia—Capecitabine—prostate cancer	4.69e-05	0.000191	CcSEcCtD
Trandolapril—Pruritus—Etoposide—prostate cancer	4.68e-05	0.000191	CcSEcCtD
Trandolapril—Shock—Prednisone—prostate cancer	4.67e-05	0.00019	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—prostate cancer	4.66e-05	0.00019	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—prostate cancer	4.66e-05	0.00019	CcSEcCtD
Trandolapril—Nervous system disorder—Prednisone—prostate cancer	4.65e-05	0.00019	CcSEcCtD
Trandolapril—Tachycardia—Prednisone—prostate cancer	4.63e-05	0.000189	CcSEcCtD
Trandolapril—Decreased appetite—Capecitabine—prostate cancer	4.63e-05	0.000189	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—prostate cancer	4.61e-05	0.000188	CcSEcCtD
Trandolapril—Skin disorder—Prednisone—prostate cancer	4.61e-05	0.000188	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Capecitabine—prostate cancer	4.6e-05	0.000187	CcSEcCtD
Trandolapril—Fatigue—Capecitabine—prostate cancer	4.59e-05	0.000187	CcSEcCtD
Trandolapril—Hyperhidrosis—Prednisone—prostate cancer	4.59e-05	0.000187	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—prostate cancer	4.57e-05	0.000186	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—prostate cancer	4.57e-05	0.000186	CcSEcCtD
Trandolapril—Constipation—Capecitabine—prostate cancer	4.55e-05	0.000186	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—prostate cancer	4.55e-05	0.000185	CcSEcCtD
Trandolapril—Feeling abnormal—Docetaxel—prostate cancer	4.53e-05	0.000185	CcSEcCtD
Trandolapril—Diarrhoea—Etoposide—prostate cancer	4.53e-05	0.000185	CcSEcCtD
Trandolapril—Anorexia—Prednisone—prostate cancer	4.52e-05	0.000184	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—prostate cancer	4.51e-05	0.000184	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—LEP—prostate cancer	4.51e-05	0.000866	CbGpPWpGaD
Trandolapril—Tinnitus—Doxorubicin—prostate cancer	4.5e-05	0.000184	CcSEcCtD
Trandolapril—Gastrointestinal pain—Docetaxel—prostate cancer	4.5e-05	0.000183	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.49e-05	0.000863	CbGpPWpGaD
Trandolapril—Flushing—Doxorubicin—prostate cancer	4.48e-05	0.000183	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—prostate cancer	4.48e-05	0.000183	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—prostate cancer	4.48e-05	0.000183	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—prostate cancer	4.45e-05	0.000181	CcSEcCtD
Trandolapril—Back pain—Epirubicin—prostate cancer	4.4e-05	0.000179	CcSEcCtD
Trandolapril—Feeling abnormal—Capecitabine—prostate cancer	4.39e-05	0.000179	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—prostate cancer	4.38e-05	0.000179	CcSEcCtD
Trandolapril—Dizziness—Etoposide—prostate cancer	4.38e-05	0.000178	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—prostate cancer	4.37e-05	0.000178	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—prostate cancer	4.36e-05	0.000178	CcSEcCtD
Trandolapril—Gastrointestinal pain—Capecitabine—prostate cancer	4.35e-05	0.000178	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—prostate cancer	4.35e-05	0.000178	CcSEcCtD
Trandolapril—Abdominal pain—Docetaxel—prostate cancer	4.35e-05	0.000177	CcSEcCtD
Trandolapril—Body temperature increased—Docetaxel—prostate cancer	4.35e-05	0.000177	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Prednisone—prostate cancer	4.32e-05	0.000176	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—prostate cancer	4.32e-05	0.000176	CcSEcCtD
Trandolapril—Insomnia—Prednisone—prostate cancer	4.29e-05	0.000175	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	4.27e-05	0.000821	CbGpPWpGaD
Trandolapril—Alopecia—Doxorubicin—prostate cancer	4.27e-05	0.000174	CcSEcCtD
Trandolapril—Paraesthesia—Prednisone—prostate cancer	4.26e-05	0.000174	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—prostate cancer	4.23e-05	0.000173	CcSEcCtD
Trandolapril—Urticaria—Capecitabine—prostate cancer	4.23e-05	0.000172	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—prostate cancer	4.22e-05	0.000172	CcSEcCtD
Trandolapril—Body temperature increased—Capecitabine—prostate cancer	4.21e-05	0.000172	CcSEcCtD
Trandolapril—Abdominal pain—Capecitabine—prostate cancer	4.21e-05	0.000172	CcSEcCtD
Trandolapril—Vomiting—Etoposide—prostate cancer	4.21e-05	0.000172	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—prostate cancer	4.21e-05	0.000171	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—prostate cancer	4.2e-05	0.000171	CcSEcCtD
Trandolapril—Agitation—Epirubicin—prostate cancer	4.18e-05	0.00017	CcSEcCtD
Trandolapril—Dyspepsia—Prednisone—prostate cancer	4.18e-05	0.00017	CcSEcCtD
Trandolapril—Rash—Etoposide—prostate cancer	4.17e-05	0.00017	CcSEcCtD
Trandolapril—Dermatitis—Etoposide—prostate cancer	4.17e-05	0.00017	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.17e-05	0.000801	CbGpPWpGaD
Trandolapril—Headache—Etoposide—prostate cancer	4.15e-05	0.000169	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—prostate cancer	4.14e-05	0.000169	CcSEcCtD
Trandolapril—Decreased appetite—Prednisone—prostate cancer	4.12e-05	0.000168	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—prostate cancer	4.12e-05	0.000168	CcSEcCtD
Trandolapril—Malaise—Epirubicin—prostate cancer	4.1e-05	0.000167	CcSEcCtD
Trandolapril—Fatigue—Prednisone—prostate cancer	4.09e-05	0.000167	CcSEcCtD
Trandolapril—Vertigo—Epirubicin—prostate cancer	4.08e-05	0.000166	CcSEcCtD
Trandolapril—Syncope—Epirubicin—prostate cancer	4.08e-05	0.000166	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—prostate cancer	4.07e-05	0.000166	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—prostate cancer	4.07e-05	0.000166	CcSEcCtD
Trandolapril—Constipation—Prednisone—prostate cancer	4.06e-05	0.000165	CcSEcCtD
Trandolapril—Hypersensitivity—Docetaxel—prostate cancer	4.05e-05	0.000165	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—prostate cancer	4.04e-05	0.000165	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—prostate cancer	4.02e-05	0.000164	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—prostate cancer	4e-05	0.000163	CcSEcCtD
Trandolapril—Cough—Epirubicin—prostate cancer	3.97e-05	0.000162	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	3.96e-05	0.000762	CbGpPWpGaD
Trandolapril—Asthenia—Docetaxel—prostate cancer	3.95e-05	0.000161	CcSEcCtD
Trandolapril—Nausea—Etoposide—prostate cancer	3.93e-05	0.00016	CcSEcCtD
Trandolapril—Hypersensitivity—Capecitabine—prostate cancer	3.92e-05	0.00016	CcSEcCtD
Trandolapril—Feeling abnormal—Prednisone—prostate cancer	3.91e-05	0.000159	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—prostate cancer	3.9e-05	0.000159	CcSEcCtD
Trandolapril—Pruritus—Docetaxel—prostate cancer	3.89e-05	0.000159	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—prostate cancer	3.89e-05	0.000158	CcSEcCtD
Trandolapril—Gastrointestinal pain—Prednisone—prostate cancer	3.88e-05	0.000158	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—prostate cancer	3.87e-05	0.000158	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—prostate cancer	3.87e-05	0.000158	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—prostate cancer	3.87e-05	0.000158	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—prostate cancer	3.86e-05	0.000158	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—prostate cancer	3.86e-05	0.000157	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—INS—prostate cancer	3.85e-05	0.00074	CbGpPWpGaD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.84e-05	0.000157	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—prostate cancer	3.82e-05	0.000156	CcSEcCtD
Trandolapril—Asthenia—Capecitabine—prostate cancer	3.82e-05	0.000156	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—prostate cancer	3.79e-05	0.000155	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—prostate cancer	3.78e-05	0.000154	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—prostate cancer	3.78e-05	0.000154	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—prostate cancer	3.77e-05	0.000154	CcSEcCtD
Trandolapril—Urticaria—Prednisone—prostate cancer	3.77e-05	0.000154	CcSEcCtD
Trandolapril—Pruritus—Capecitabine—prostate cancer	3.77e-05	0.000154	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—prostate cancer	3.76e-05	0.000153	CcSEcCtD
Trandolapril—Diarrhoea—Docetaxel—prostate cancer	3.76e-05	0.000153	CcSEcCtD
Trandolapril—Abdominal pain—Prednisone—prostate cancer	3.75e-05	0.000153	CcSEcCtD
Trandolapril—Body temperature increased—Prednisone—prostate cancer	3.75e-05	0.000153	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—IGF1—prostate cancer	3.72e-05	0.000716	CbGpPWpGaD
Trandolapril—Palpitations—Doxorubicin—prostate cancer	3.72e-05	0.000152	CcSEcCtD
Trandolapril—Oedema—Epirubicin—prostate cancer	3.71e-05	0.000151	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—prostate cancer	3.7e-05	0.000151	CcSEcCtD
Trandolapril—Infection—Epirubicin—prostate cancer	3.69e-05	0.00015	CcSEcCtD
Trandolapril—Cough—Doxorubicin—prostate cancer	3.67e-05	0.00015	CcSEcCtD
Trandolapril—Shock—Epirubicin—prostate cancer	3.65e-05	0.000149	CcSEcCtD
Trandolapril—Diarrhoea—Capecitabine—prostate cancer	3.64e-05	0.000149	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—prostate cancer	3.64e-05	0.000148	CcSEcCtD
Trandolapril—Dizziness—Docetaxel—prostate cancer	3.64e-05	0.000148	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—prostate cancer	3.63e-05	0.000148	CcSEcCtD
Trandolapril—Tachycardia—Epirubicin—prostate cancer	3.62e-05	0.000148	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—MMP2—prostate cancer	3.6e-05	0.000693	CbGpPWpGaD
Trandolapril—Skin disorder—Epirubicin—prostate cancer	3.6e-05	0.000147	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—prostate cancer	3.59e-05	0.000146	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—prostate cancer	3.58e-05	0.000146	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—prostate cancer	3.58e-05	0.000146	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—prostate cancer	3.58e-05	0.000146	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—prostate cancer	3.57e-05	0.000145	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.56e-05	0.000145	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—prostate cancer	3.54e-05	0.000144	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—prostate cancer	3.54e-05	0.000144	CcSEcCtD
Trandolapril—Dizziness—Capecitabine—prostate cancer	3.52e-05	0.000144	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—prostate cancer	3.5e-05	0.000143	CcSEcCtD
Trandolapril—Vomiting—Docetaxel—prostate cancer	3.5e-05	0.000143	CcSEcCtD
Trandolapril—Hypersensitivity—Prednisone—prostate cancer	3.49e-05	0.000142	CcSEcCtD
Trandolapril—Rash—Docetaxel—prostate cancer	3.47e-05	0.000141	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—prostate cancer	3.47e-05	0.000141	CcSEcCtD
Trandolapril—Dermatitis—Docetaxel—prostate cancer	3.46e-05	0.000141	CcSEcCtD
Trandolapril—Headache—Docetaxel—prostate cancer	3.45e-05	0.00014	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—prostate cancer	3.43e-05	0.00014	CcSEcCtD
Trandolapril—Infection—Doxorubicin—prostate cancer	3.41e-05	0.000139	CcSEcCtD
Trandolapril—Asthenia—Prednisone—prostate cancer	3.4e-05	0.000139	CcSEcCtD
Trandolapril—Vomiting—Capecitabine—prostate cancer	3.39e-05	0.000138	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.38e-05	0.000138	CcSEcCtD
Trandolapril—Shock—Doxorubicin—prostate cancer	3.38e-05	0.000138	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—prostate cancer	3.37e-05	0.000137	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—prostate cancer	3.36e-05	0.000137	CcSEcCtD
Trandolapril—Rash—Capecitabine—prostate cancer	3.36e-05	0.000137	CcSEcCtD
Trandolapril—Pruritus—Prednisone—prostate cancer	3.36e-05	0.000137	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—prostate cancer	3.36e-05	0.000137	CcSEcCtD
Trandolapril—Dermatitis—Capecitabine—prostate cancer	3.35e-05	0.000137	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—prostate cancer	3.35e-05	0.000137	CcSEcCtD
Trandolapril—Headache—Capecitabine—prostate cancer	3.34e-05	0.000136	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—prostate cancer	3.33e-05	0.000136	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—prostate cancer	3.33e-05	0.000136	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—prostate cancer	3.32e-05	0.000135	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—prostate cancer	3.31e-05	0.000135	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—prostate cancer	3.3e-05	0.000134	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—prostate cancer	3.27e-05	0.000133	CcSEcCtD
Trandolapril—Nausea—Docetaxel—prostate cancer	3.27e-05	0.000133	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—prostate cancer	3.27e-05	0.000133	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	3.26e-05	0.000627	CbGpPWpGaD
Trandolapril—Diarrhoea—Prednisone—prostate cancer	3.25e-05	0.000132	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—prostate cancer	3.22e-05	0.000131	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—prostate cancer	3.21e-05	0.000131	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—prostate cancer	3.2e-05	0.000131	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—prostate cancer	3.2e-05	0.00013	CcSEcCtD
Trandolapril—Constipation—Epirubicin—prostate cancer	3.17e-05	0.000129	CcSEcCtD
Trandolapril—Nausea—Capecitabine—prostate cancer	3.16e-05	0.000129	CcSEcCtD
Trandolapril—Dizziness—Prednisone—prostate cancer	3.14e-05	0.000128	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.13e-05	0.000127	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—prostate cancer	3.1e-05	0.000127	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—prostate cancer	3.08e-05	0.000126	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—prostate cancer	3.06e-05	0.000125	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—prostate cancer	3.06e-05	0.000125	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—prostate cancer	3.05e-05	0.000124	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—prostate cancer	3.03e-05	0.000124	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.03e-05	0.000582	CbGpPWpGaD
Trandolapril—Dyspepsia—Doxorubicin—prostate cancer	3.02e-05	0.000123	CcSEcCtD
Trandolapril—Vomiting—Prednisone—prostate cancer	3.02e-05	0.000123	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—CXCL8—prostate cancer	3e-05	0.000576	CbGpPWpGaD
Trandolapril—Rash—Prednisone—prostate cancer	2.99e-05	0.000122	CcSEcCtD
Trandolapril—Dermatitis—Prednisone—prostate cancer	2.99e-05	0.000122	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—prostate cancer	2.98e-05	0.000122	CcSEcCtD
Trandolapril—Headache—Prednisone—prostate cancer	2.97e-05	0.000121	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.96e-05	0.000121	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—prostate cancer	2.96e-05	0.000121	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—prostate cancer	2.95e-05	0.00012	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—prostate cancer	2.94e-05	0.00012	CcSEcCtD
Trandolapril—Body temperature increased—Epirubicin—prostate cancer	2.93e-05	0.00012	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—prostate cancer	2.93e-05	0.00012	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—prostate cancer	2.83e-05	0.000115	CcSEcCtD
Trandolapril—Nausea—Prednisone—prostate cancer	2.82e-05	0.000115	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—prostate cancer	2.81e-05	0.000114	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—CTNNB1—prostate cancer	2.76e-05	0.000531	CbGpPWpGaD
Trandolapril—Hypersensitivity—Epirubicin—prostate cancer	2.73e-05	0.000111	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—prostate cancer	2.73e-05	0.000111	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—prostate cancer	2.71e-05	0.000111	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—prostate cancer	2.71e-05	0.000111	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—prostate cancer	2.66e-05	0.000109	CcSEcCtD
Trandolapril—Pruritus—Epirubicin—prostate cancer	2.62e-05	0.000107	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.59e-05	0.000498	CbGpPWpGaD
Trandolapril—Diarrhoea—Epirubicin—prostate cancer	2.54e-05	0.000103	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—prostate cancer	2.53e-05	0.000103	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—prostate cancer	2.46e-05	0.0001	CcSEcCtD
Trandolapril—Dizziness—Epirubicin—prostate cancer	2.45e-05	0.0001	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—prostate cancer	2.43e-05	9.9e-05	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.4e-05	0.000462	CbGpPWpGaD
Trandolapril—Vomiting—Epirubicin—prostate cancer	2.36e-05	9.62e-05	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—prostate cancer	2.35e-05	9.57e-05	CcSEcCtD
Trandolapril—Rash—Epirubicin—prostate cancer	2.34e-05	9.53e-05	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—prostate cancer	2.34e-05	9.53e-05	CcSEcCtD
Trandolapril—Headache—Epirubicin—prostate cancer	2.32e-05	9.47e-05	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—prostate cancer	2.27e-05	9.25e-05	CcSEcCtD
Trandolapril—Nausea—Epirubicin—prostate cancer	2.2e-05	8.98e-05	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—prostate cancer	2.18e-05	8.9e-05	CcSEcCtD
Trandolapril—Rash—Doxorubicin—prostate cancer	2.16e-05	8.82e-05	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—prostate cancer	2.16e-05	8.81e-05	CcSEcCtD
Trandolapril—Headache—Doxorubicin—prostate cancer	2.15e-05	8.77e-05	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—prostate cancer	2.04e-05	8.31e-05	CcSEcCtD
